Emerging evidence suggests that ascorbate, the dominant form of vitamin C under physiological pH conditions, influences activity of the genome via regulating epigenomic processes. Ascorbate serves as a cofactor for Ten-eleven translocation (TET) dioxygenases that catalyze the oxidation of 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC), and further to 5-formylcytosine (5fC) and to 5-carboxylcytosine (5caC), which are ultimately replaced by unmodified cytosine. The Jumonji C (JmjC)-domain-containing histone demethylases also require ascorbate as a cofactor for histone demethylation. Thus, by primarily participating in the demethylation of both DNA and histones, ascorbate appears to be a mediator of the interface between the genome and environment. Furthermore, redox status has a profound impact on the bioavailability of ascorbate in the nucleus. In order to bridge the gap between redox biology and genomics, we suggest an interdisciplinary research field that can be termed redox genomics to study dynamic redox processes in health and diseases. This review examines the evidence and potential molecular mechanism of ascorbate in the demethylation of the genome, and it highlights potential epigenetic roles of ascorbate in various diseases.

[Erratum, Closure]

An erratum has been published for this article:
Regulation of the Epigenome by Vitamin C

Article metrics loading...

Loading full text...

Full text loading...


Literature Cited

  1. Babiarz J, Kane-Goldsmith N, Basak S, Liu K, Young W, Grumet M. 1.  2011. Juvenile and adult olfactory ensheathing cells bundle and myelinate dorsal root ganglion axons in culture. Exp. Neurol. 229:72–79 [Google Scholar]
  2. Blaschke K, Ebata KT, Karimi MM, Zepeda-Martínez JA, Goyal P. 2.  et al. 2013. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500:222–26 [Google Scholar]
  3. Brender JD, Werler MM, Kelley KE, Vuong AM, Shinde MU. 3.  et al. The National Birth Defects Prevention Study 2011. Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention Study. Am. J. Epidemiol. 174:1286–95 [Google Scholar]
  4. Brocato J, Costa M. 4.  2014. 10th NTES Conference: Nickel and arsenic compounds alter the epigenome of peripheral blood mononuclear cells. J. Trace Elem. Med. Biol. doi: 10.1016/j.jtemb.2014.04.001 [Google Scholar]
  5. Bunge RP, Bunge MB, Eldridge CF. 5.  1986. Linkage between axonal ensheathment and basal lamina production by Schwann cells. Annu. Rev. Neurosci. 9:305–28 [Google Scholar]
  6. Burns J, Ouvrier RA, Yiu EM, Joseph PD, Kornberg AJ. 6.  et al. 2009. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol. 8:537–44 [Google Scholar]
  7. Cameron E, Pauling L. 6a.  1976. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. PNAS 73:3685–89 [Google Scholar]
  8. Chen J, Guo L, Zhang L, Wu H, Yang J. 7.  et al. 2013. Vitamin C modulates Tet1 function during somatic cell reprogramming. Nat. Genet. 45:1504–9 [Google Scholar]
  9. Chen J, Liu H, Liu J, Qi J, Wei B. 8.  et al. 2013. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat. Genet. 45:34–42 [Google Scholar]
  10. Chen ML, Shen F, Huang W, Qi JH, Wang Y. 9.  et al. 2013. Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole time-of-flight mass spectrometry. Clin. Chem. 59:824–32 [Google Scholar]
  11. Chen Q, Gao S, He W, Kou X, Zhao Y. 10.  et al. 2014. Xist repression shows time-dependent effects on the reprogramming of female somatic cells to induced pluripotent stem cells. Stem Cells 32:2642–56 [Google Scholar]
  12. Chung TL, Brena RM, Kolle G, Grimmond SM, Berman BP. 11.  et al. 2010. Vitamin C promotes widespread yet specific DNA demethylation of the epigenome in human embryonic stem cells. Stem Cells 28:1848–55 [Google Scholar]
  13. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S. 12.  et al. 2009. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 360:2289–301 [Google Scholar]
  14. Dickson KM, Gustafson CB, Young JI, Züchner S, Wang G. 13.  2013. Ascorbate-induced generation of 5-hydroxymethylcytosine is unaffected by varying levels of iron and 2-oxoglutarate. Biochem. Biophys. Res. Commun. 439:522–27 [Google Scholar]
  15. Doege CA, Inoue K, Yamashita T, Rhee DB, Travis S. 14.  et al. 2012. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 488:652–55 [Google Scholar]
  16. Eldridge CF, Bunge MB, Bunge RP, Wood PM. 15.  1987. Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J. Cell Biol. 105:1023–34 [Google Scholar]
  17. Erichsen HC, Engel SA, Eck PK, Welch R, Yeager M. 16.  et al. 2006. Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. Am. J. Epidemiol. 163:245–54 [Google Scholar]
  18. Erichsen HC, Peters U, Eck P, Welch R, Schoen RE. 17.  et al. 2008. Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr. Cancer 60:652–59 [Google Scholar]
  19. Esteban MA, Wang T, Qin B, Yang J, Qin D. 18.  et al. 2010. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6:71–79 [Google Scholar]
  20. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J. 19.  et al. 2010. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18:553–67 [Google Scholar]
  21. Gess B, Lohmann C, Halfter H, Young P. 20.  2010. Sodium-dependent vitamin C transporter 2 (SVCT2) is necessary for the uptake of L-ascorbic acid into Schwann cells. Glia 58:287–99 [Google Scholar]
  22. Gess B, Röhr D, Fledrich R, Sereda MW, Kleffner I. 21.  et al. 2011. Sodium-dependent vitamin C transporter 2 deficiency causes hypomyelination and extracellular matrix defects in the peripheral nervous system. J. Neurosci. 31:17180–92 [Google Scholar]
  23. Gess B, Röhr D, Young P. 22.  2013. Ascorbic acid and sodium-dependent vitamin C transporters in the peripheral nervous system: from basic science to clinical trials. Antioxid. Redox Signal. 19:2105–14 [Google Scholar]
  24. Gorres KL, Raines RT. 23.  2010. Prolyl 4-hydroxylase. Crit. Rev. Biochem. Mol. Biol. 45:106–24 [Google Scholar]
  25. Greer EL, Shi Y. 24.  2012. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13:343–57 [Google Scholar]
  26. Guey LT, García-Closas M, Murta-Nascimento C, Lloreta J, Palencia L. 25.  et al. EPICURO/Spanish Bladder Cancer Study investigators 2010. Genetic susceptibility to distinct bladder cancer subphenotypes. Eur. Urol. 57:283–92 [Google Scholar]
  27. Guo JU, Su Y, Zhong C, Ming GL, Song H. 26.  2011. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145:423–34 [Google Scholar]
  28. Harbour JW, Roberson ED, Anbunathan H, Onken MD, Worley LA, Bowcock AM. 27.  2013. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat. Genet. 45:133–35 [Google Scholar]
  29. Harris HR, Orsini N, Wolk A. 28.  2014. Vitamin C and survival among women with breast cancer: a meta-analysis. Eur. J. Cancer 50:1223–31 [Google Scholar]
  30. He YF, Li BZ, Li Z, Liu P, Wang Y. 29.  et al. 2011. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333:1303–7 [Google Scholar]
  31. Hodges RE, Baker EM, Hood J, Sauberlich HE, March SC. 30.  1969. Experimental scurvy in man. Am. J. Clin. Nutr. 22:535–48 [Google Scholar]
  32. Hood J. 31.  1969. Femoral neuropathy in scurvy. N. Engl. J. Med. 281:1292–93 [Google Scholar]
  33. Hsu CH, Peng KL, Kang ML, Chen YR, Yang YC. 32.  et al. 2012. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep. 2:568–79 [Google Scholar]
  34. Inoue A, Zhang Y. 33.  2011. Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 334:194 [Google Scholar]
  35. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. 34.  2010. Role of TET dioxygenases in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466:1129–33 [Google Scholar]
  36. Ito S, Shen L, Dai Q, Wu SC, Collins LB. 35.  et al. 2011. TET dioxygenases can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333:1300–3 [Google Scholar]
  37. Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y. 36.  et al. 2011. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 71:7360–65 [Google Scholar]
  38. Justin N, De Marco V, Aasland R, Gamblin SJ. 37.  2010. Reading, writing and editing methylated lysines on histone tails: new insights from recent structural studies. Curr. Opin. Struct. Biol. 20:730–38 [Google Scholar]
  39. Karytinos A, Forneris F, Profumo A, Ciossani G, Battaglioli E. 38.  et al. 2009. A novel mammalian flavin-dependent histone demethylase. J. Biol. Chem. 284:17775–82 [Google Scholar]
  40. Klose RJ, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H. 39.  et al. 2006. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 442:312–16 [Google Scholar]
  41. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M. 40.  et al. 2010. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468:839–43 [Google Scholar]
  42. Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K. 41.  et al. 2011. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 8:200–13 [Google Scholar]
  43. Kohli RM, Zhang Y. 42.  2013. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502:472–79 [Google Scholar]
  44. Koshiishi I, Mamura Y, Liu J, Imanari T. 43.  1998. Evaluation of an acidic deproteinization for the measurement of ascorbate and dehydroascorbate in plasma samples. Clin. Chem. 44:863–68 [Google Scholar]
  45. Kriaucionis S, Heintz N. 44.  2009. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324:929–30 [Google Scholar]
  46. Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y. 45.  et al. 2012. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci. 103:670–76 [Google Scholar]
  47. Lane DJ, Chikhani S, Richardson V, Richardson DR. 46.  2013. Transferrin iron uptake is stimulated by ascorbate via an intracellular reductive mechanism. Biochim. Biophys. Acta 1833:1527–41 [Google Scholar]
  48. Lane DJ, Lawen A. 47.  2008. Non-transferrin iron reduction and uptake are regulated by transmembrane ascorbate cycling in K562 cells. J. Biol. Chem. 283:12701–8 [Google Scholar]
  49. Lane DJ, Robinson SR, Czerwinska H, Bishop GM, Lawen A. 48.  2010. Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. Biochem. J. 432:123–32 [Google Scholar]
  50. Lian CG, Xu Y, Ceol C, Wu F, Larson A. 49.  et al. 2012. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150:1135–46 [Google Scholar]
  51. Linster CL, Van Schaftingen E. 50.  2007. Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J. 274:1–22 [Google Scholar]
  52. Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing JR. 51.  2003. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 17:637–41 [Google Scholar]
  53. Luo J, Shen L, Zheng D. 52.  2014. Association between vitamin C intake and lung cancer: a dose-response meta-analysis. Sci. Rep. 4:6161 [Google Scholar]
  54. Maiti A, Drohat AC. 53.  2011. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J. Biol. Chem. 286:35334–38 [Google Scholar]
  55. Mandl J, Szarka A, Bánhegyi G. 54.  2009. Vitamin C: update on physiology and pharmacology. Br. J. Pharmacol. 157:1097–110 [Google Scholar]
  56. Manning J, Mitchell B, Appadurai DA, Shakya A, Pierce LJ. 55.  et al. 2013. Vitamin C promotes maturation of T-cells. Antioxid. Redox Signal. 19:2054–67 [Google Scholar]
  57. Mashima Y, Kigasawa K, Wakakura M, Oguchi Y. 56.  2000. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?. J. Neuroophthalmol. 20:166–70 [Google Scholar]
  58. Mason EF, Hornick JL. 57.  2013. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis. Mod. Pathol. 26:1492–97 [Google Scholar]
  59. May JM. 58.  2011. The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C. Br. J. Pharmacol. 164:1793–801 [Google Scholar]
  60. McDonough MA, Loenarz C, Chowdhury R, Clifton IJ, Schofield CJ. 59.  2010. Structural studies on human 2-oxoglutarate dependent oxygenases. Curr. Opin. Struct. Biol. 20:659–72 [Google Scholar]
  61. McGarvey ML, Baron-Van Evercooren A, Kleinman HK, Dubois-Dalcq M. 60.  1984. Synthesis and effects of basement membrane components in cultured rat Schwann cells. Dev. Biol. 105:18–28 [Google Scholar]
  62. Michels AJ, Joisher N, Hagen TM. 61.  2003. Age-related decline of sodium-dependent ascorbic acid transport in isolated rat hepatocytes. Arch. Biochem. Biophys. 410:112–20 [Google Scholar]
  63. Minor EM, Court BL, Young JI, Wang G. 62.  2013. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J. Biol. Chem. 288:13669–74 [Google Scholar]
  64. Monfort A, Wutz A. 63.  2013. Breathing-in epigenetic change with vitamin C. EMBO Rep. 14:337–46 [Google Scholar]
  65. Mosammaparast N, Shi Y. 64.  2010. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 79:155–79 [Google Scholar]
  66. Müller T, Gessi M, Waha A, Isselstein LJ, Luxen D. 65.  et al. 2012. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas. Am. J. Pathol. 181:675–83 [Google Scholar]
  67. Olsen CL, Bunge RP. 66.  1986. Requisites for growth and myelination of urodele sensory neurons in tissue culture. J. Exp. Zool. 238:373–84 [Google Scholar]
  68. Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. 67.  2012. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLOS ONE 7:e41036 [Google Scholar]
  69. Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T. 68.  et al. CMT-TRIAAL, CMT-TRAUK groups 2011. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol. 10:320–28 [Google Scholar]
  70. Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J. 69.  et al. 2004. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med. 10:396–401 [Google Scholar]
  71. Penn NW, Suwalski R, O'Riley C, Bojanowski K, Yura R. 70.  1972. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem. J. 126:781–90 [Google Scholar]
  72. Pérez C, Martínez-Calle N, Martín-Subero JI, Segura V, Delabesse E. 71.  et al. 2012. TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia. PLOS ONE 7:e31605 [Google Scholar]
  73. Quesada V, Conde L, Villamor N, Ordóñez GR, Jares P. 72.  et al. 2011. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat. Genet. 44:47–52 [Google Scholar]
  74. Rice ME, Russo-Menna I. 73.  1998. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 82:1213–23 [Google Scholar]
  75. Rossor AM, Polke JM, Houlden H, Reilly MM. 74.  2013. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat. Rev. Neurol. 9:562–71 [Google Scholar]
  76. Rothbart SB, Strahl BD. 75.  2014. Interpreting the language of histone and DNA modifications. Biochim. Biophys. Acta 1839:627–43 [Google Scholar]
  77. Schleicher RL, Carroll MD, Ford ES, Lacher DA. 76.  2009. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003–2004 National Health and Nutrition Examination Survey (NHANES). Am. J. Clin. Nutr. 90:1252–63 [Google Scholar]
  78. Schorah CJ, Wild J, Hartley R, Sheppard S, Smithells RW. 77.  1983. The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defect. Br. J. Nutr. 49:203–11 [Google Scholar]
  79. Shen L, Zhang Y. 78.  2013. 5-Hydroxymethylcytosine: generation, fate, and genomic distribution. Curr. Opin. Cell Biol. 25:289–96 [Google Scholar]
  80. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR. 79.  et al. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941–53 [Google Scholar]
  81. Shi YG, Tsukada Y. 80.  2013. The discovery of histone demethylases. Cold Spring Harb. Perspect. Biol. 5:a017947 [Google Scholar]
  82. Simpson GL, Ortwerth BJ. 81.  2000. The non-oxidative degradation of ascorbic acid at physiological conditions. Biochim. Biophys. Acta 1501:12–24 [Google Scholar]
  83. Skibola CF, Bracci PM, Halperin E, Nieters A, Hubbard A. 82.  et al. 2008. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. PLOS ONE 3:e2816 [Google Scholar]
  84. Spielholz C, Golde DW, Houghton AN, Nualart F, Vera JC. 83.  1997. Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells. Cancer Res. 57:2529–37 [Google Scholar]
  85. Stadtfeld M, Apostolou E, Ferrari F, Choi J, Walsh RM. 84.  et al. 2012. Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat. Genet. 44:398–405 [Google Scholar]
  86. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H. 85.  et al. 2009. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930–35 [Google Scholar]
  87. Tan L, Shi YG. 86.  2012. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 139:1895–902 [Google Scholar]
  88. Timpson NJ, Forouhi NG, Brion MJ, Harbord RM, Cook DG. 87.  et al. 2010. Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. Am. J. Clin. Nutr. 92:375–82 [Google Scholar]
  89. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH. 88.  et al. 2006. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439:811–16 [Google Scholar]
  90. Wang L, Zhang J, Duan J, Gao X, Zhu W. 89.  et al. 2014. Programming and inheritance of parental DNA methylomes in mammals. Cell 157:979–91 [Google Scholar]
  91. Wang T, Chen K, Zeng X, Yang J, Wu Y. 90.  et al. 2011. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 9:575–87 [Google Scholar]
  92. Wilson JX. 91.  2005. Regulation of vitamin C transport. Annu. Rev. Nutr. 25:105–25 [Google Scholar]
  93. Wright ME, Andreotti G, Lissowska J, Yeager M, Zatonski W. 92.  et al. 2009. Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland. Eur. J. Cancer 45:1824–30 [Google Scholar]
  94. Wyatt GR, Cohen SS. 93.  1952. A new pyrimidine base from bacteriophage nucleic acids. Nature 170:1072–73 [Google Scholar]
  95. Xu W, Yang H, Liu Y, Yang Y, Wang P. 94.  et al. 2011. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17–30 [Google Scholar]
  96. Yang H, Liu Y, Bai F, Zhang JY, Ma SH. 95.  et al. 2013. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 32:663–69 [Google Scholar]
  97. Yin R, Mao SQ, Zhao B, Chong Z, Yang Y. 96.  et al. 2013. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J. Am. Chem. Soc. 135:10396–403 [Google Scholar]
  98. Yulin X, Lizhen L, Lifei Z, Shan F, Ru L. 97.  et al. 2012. Efficient generation of induced pluripotent stem cells from human bone marrow mesenchymal stem cells. Folia Biol. (Praha) 58:221–23 [Google Scholar]

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error